Thailand - Stop TB Partnership

136. WHO, Global Tuberculosis Control: Surveillance, Planning, Financing, (Geneva: WHO, 2005), p. 131.
137. K. Rookkapan and N. Poomviset, “Problems of anti-tuberculosis drug management in Southern
Thailand.” Paper presented at 17th Annual academic Meeting, Faculty of Medicine, Prince Songkla
University, Hat Yai, Songkla, August 15–17, 2001. Available at www.clib.psu.ac.th/acad_44/rkorng1.htm
(accessed March 24, 2006).
138. K. Rookkapan and N. Poomviset, “Problems of anti-tuberculosis drug management in Southern
Thailand” Paper presented at 17th Annual Academic Meeting, Faculty of Medicine, Prince Songkla
University, Hat Yai, Songkla, August 15–17, 2001. Available at www.clib.psu.ac.th/acad_44/rkorng1.htm
(accessed March 24, 2006).
139. Participants in Public Health Watch roundtable meetings, Bangkok and Chiang Mai, December 2005.
140. Comment at Public Health Watch roundtable meeting, Bangkok, December 6, 2005.
141. Comment by Pruthi Israngkul Na Ayudya, director, BMA Health Center 21, Public Health Watch
roundtable meeting, Bangkok, December 6, 2005.
142. Interview with TB clinic staff, Health Center 21, Bangkok, December 13, 2005.
143. Interview with Ankana Chaiprasert, Faculty of Medicine, Mahidol University, March 24, 2005.
144. Interview with Samran Takan, director of New Life Friend Center, Chiang Mai, December 13, 2005.
145. For example, the Thai NGO Coalition on AIDS (TNCA) and the Thai Network of People with HIV
(TNP+) each represent over 300 organizations, and both are represented on the National Committee.
146. One organization of people living with HIV/AIDS established a group of more than 100 volunteers
to educate people with HIV on risk reduction and encourage peer care and support. Interview with
Samran Takan, director of New Life Friend Center, Chiang Mai, January 18, 2005.
147. Bureau of Policy and Strategy, Ministry of Public Health (MoPH), Health Policy in Thailand, 2003, p. 7.
148. Interview with Sirinapha Jittimanee, public health officer, TB Cluster, Bangkok, December 7, 2005.
149. Comments by Suksont Jittimanee, Bureau of AIDS, TB, and STIs, MoPH, Public Health Watch
roundtable meeting, Bangkok, December 6, 2005, and participants at Public Health Watch roundtable
meeting, Chiang Mai, December 9, 2005.
150. Comment by Jutatip Chaisakul, Health Development Networks, Publc Health Watch roundtable
meeting, Chiang Mai, December 9, 2005.
151. Comment by Prasert Dechabon, president, Northern PWA Network, Public Health Watch roundtable
meeting, Chiang Mai, December 9, 2005.
152. Comment by Voravit Suwanvanichkij, Public Health Watch roundtable meeting, Chiang Mai, December
9, 2005.
153. Comment by UNAIDS representative, Public Health Watch roundtable meeting, Bangkok, December 6,
2005.
154. Comment by Somsak Akksilp, director, Office of Disease Prevention and Control Region 7, Public
Health Watch roundtable meeting, Bangkok, December 6, 2005.
155. Comment by Sumalee Amarinsangpen, Office of Disease Prevention and Control Region 10, Public
Health Watch roundtable meeting, Chiang Mai, December 9, 2005.
156. Comment by Pruthi Isrankul Na Ayudya, director, Health Center 21, Public Health Watch roundtable
meeting, Bangkok, December 6, 2005. The CDC is also supporting a range of other TB control
activities, including: TB prevention activities targeting vulnerable groups such as injection drug users,
high-risk youth, and people living with HIV/AIDS; improving TB laboratory and diagnostic services; and
TB surveillance. Written comments by Jay Varma, section chief for TB Prevention and Control of the
Thailand–U.S. Collaboration (TUC) and internist and epidemiologist, U.S. Centers for Disease Control
and Prevention, Bangkok, December 2005.
157. Comment by Ankana Chaiprasert, Faculty of Medicine, Mahidol University, Public Health Watch
roundtable meeting, Bangkok, December 6, 2005, and a university researcher, Public Health Watch
roundtable meeting, Bangkok, December 6, 2005.
78
TB POLICY IN THAILAND